Wolverine Trading
ALXN

Wolverine Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Wolverine Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33,200
Closed -$5.09M – 7103
2021
Q1 		$5.09M Sell
33,200
-26,900
-45% -$4.16M 0.01% 1095
2020
Q4 		$9.39M Buy
60,100
+8,500
+16% +$1.09M 0.01% 713
2020
Q3 		$5.8M Sell
51,600
-13,700
-21% -$1.48M 0.01% 776
2020
Q2 		$7.26M Sell
65,300
-6,800
-9% -$722K 0.02% 612
2020
Q1 		$6.29M Buy
72,100
+17,700
+33% +$1.74M 0.02% 641
2019
Q4 		$5.84M Sell
54,400
-8,900
-14% -$952K 0.01% 990
2019
Q3 		$6.19M Buy
63,300
+18,900
+43% +$2.13M 0.02% 747
2019
Q2 		$5.82M Buy
44,400
+25,400
+134% +$3.27M 0.02% 795
2019
Q1 		$2.57M Sell
19,000
-5,600
-23% -$696K 0.01% 1329
2018
Q4 		$2.39M Buy
24,600
+1,600
+7% +$189K 0.01% 1283
2018
Q3 		$3.2M Sell
23,000
-56,100
-71% -$7.04M 0.01% 1277
2018
Q2 		$8.82M Hold
79,100
– – 0.02% 565
2018
Q1 		$8.82M Buy
+79,100
New +$9.45M 0.02% 565
2017
Q4 		– Sell
-30,300
Closed -$4.25M – 5746
2017
Q3 		$4.25M Sell
30,300
-6,600
-18% -$897K 0.02% 870
2017
Q2 		$4.52M Buy
36,900
+20,300
+122% +$2.36M 0.02% 725
2017
Q1 		$2.03M Sell
16,600
-14,000
-46% -$1.8M 0.01% 1181
2016
Q4 		$3.74M Buy
30,600
+7,100
+30% +$869K 0.02% 905
2016
Q3 		$2.82M Buy
+23,500
New +$3.02M 0.01% 1080

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Wolverine Trading's ALXN Position: Q2 2021 in Review

Wolverine Trading sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 2,917 shares — an estimated $448K sold.

Wolverine Trading first reported a position in ALXN in Q3 2016 and held it in 13 quarters. The position peaked at $2.68M in Q2 2018. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Wolverine Trading reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 2,917 Alexion Pharmaceuticals shares in Q2 2021, an estimated $448K.
  • Wolverine Trading first reported a position in Alexion Pharmaceuticals in Q3 2016 and held it in 13 quarters.
  • Wolverine Trading's Alexion Pharmaceuticals position peaked at $2.68M in Q2 2018.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.